Lupin

Lupin's reported carbon emissions

Lupin, a pharmaceutical preparation manufacturing company headquartered in India, reported a total of approximately 1.31 billion kg CO2e in emissions for fiscal year 2025. This figure encompasses Scope 1, 2, and 3 emissions, with Scope 3 being the largest contributor at approximately 1.02 billion kg CO2e. For fiscal year 2024, Lupin's total emissions were approximately 1.46 billion kg CO2e, including Scope 1 (approximately 85.68 million kg CO2e), Scope 2 (approximately 263.91 million kg CO2e), and Scope 3 (approximately 1.12 billion kg CO2e). In fiscal year 2023, the company's total emissions reached approximately 1.25 billion kg CO2e, with Scope 1 at around 86.91 million kg CO2e, Scope 2 at approximately 323.85 million kg CO2e, and Scope 3 at approximately 854.94 million kg CO2e. Lupin has established several climate commitments. The company has committed to an absolute reduction of 42.0% in Scope 1 and Scope 2 greenhouse gas (GHG) emissions by fiscal year 2030, using fiscal year 2023 as a base year. Furthermore, Lupin has pledged to reduce GHG emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, business travel, employee commuting, downstream transportation and distribution, processing of sold products, use of sold products, and franchises by 61.07% per Indian Rupee (INR) value added by fiscal year 2033, also from a fiscal year 2024 base year. These targets are aligned with keeping global warming to 1.5°C. Previously, Lupin had adopted a target to reduce its Scope 1 and Scope 2 GHG emissions by 15% by 2030. The company has also committed to an absolute reduction of 38% from fiscal year 2023 levels by 2030. Lupin is a signatory to the Climate Pledge, underscoring its commitment to sustainability initiatives. The company's emissions data and climate targets are reported by Lupin Limited.